1Takahara T,Watanabe A,Shiraki K. Effeets of glycyrrhizin on hepatitis B surface antigen :a biochemical and morphological study [J]. JHepatol, 1994,21 (4) :601.
2Sato H , Goto W, Yamamura J. The rapeutic basis of glycyrrhizin on chronic hepatitis B [J]. Antivir Res, 1996,30 ( 2 -3 ): 171.
3Kumada H. Long-term treatment of chronic hepatitis C with glycyrrhizin (stronger neominophagen C ) for preventing livercirrhosis and hepatocellular carcinoma[J]. Oncology,2002,62(1) :94.
4Melegari M, Scaglioni P P, Wands J R. Hepatitis virus mutants associated with 3TC and famiciclovir administration are replication defective[J]. Hepatology,1998,27(10) :628 -633.
5Shiki Y, Shirai K, Saito Y, et al. Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody [J]. J Gastroenterol Hepatol, 1992,7 (1): 12 - 15.
6Yamamoto Y, Yasuoka A, Tachikawa N, et al. Hepatitis C virusassociated hepatitis following treatment of HIV-infected patients with protease inhibitors: an immune restoration diseases? [J]. Jpn Infect Dis,1999,52(2) :248 -249.
7Sekizawa T, Yanagi K, Itoyama Y. Glycyrrhizin increases survival of mice with herpes simplex encephalitis. Acta Virol,2001,45:51-54.
8Kayano K, Sakaida I, Uchida K, et al. Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. Hepatology, 1998,29: 642-649.
9Ono M, Miyamura M, Kyotani S, et al. Effects of Sho-saiko-to extract on liver fibrosis in relation to the changes in hydroxyproline and retinoid levels of the liver in rats. J Pharm Pharmacol, 1999,51:1079-1084.
10Fujisawa K,Watanabe Y,Kawase H.New Treads in Peptic Ulcer and Chronic Hepatitis[M].Stockholm:Excerpta Medica,1987:127～132.
